Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J Nanobiotechnol. 2022;20(1):395.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–24.
Article PubMed CAS Google Scholar
Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181(1):151–67.
Article PubMed CAS Google Scholar
Ajith S, Almomani F, Elhissi A, Husseini GA. Nanoparticle-based materials in anticancer drug delivery: current and future prospects. Heliyon. 2023;9(11): e21227.
Article PubMed PubMed Central CAS Google Scholar
Li J, Chen C, Xia T. Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications. Adv Mater. 2022;34(11): e2106456.
Article PubMed PubMed Central Google Scholar
Jadhav V, Roy A, Kaur K, Rai AK, Rustagi S. Recent advances in nanomaterial-based drug delivery systems. Nano-Struct Nano-Objects. 2024;37:101103.
Gao J, Karp JM, Langer R, Joshi N. The future of drug delivery. Chem Mater. 2023;35(2):359–63.
Article PubMed PubMed Central CAS Google Scholar
Goraya SA, Ding S, Miller RC, Arif MK, Kong H, Masud A. Modeling of spatiotemporal dynamics of ligand-coated particle flow in targeted drug delivery processes. Proc Natl Acad Sci U S A. 2024;121(22): e2314533121.
Article PubMed CAS Google Scholar
Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS, et al. Targeting drug delivery in the vascular system: focus on endothelium. Adv Drug Deliv Rev. 2020;157:96–117.
Article PubMed PubMed Central CAS Google Scholar
Shuvaev VV, Brenner JS, Muzykantov VR. Targeted endothelial nanomedicine for common acute pathological conditions. J Control Release. 2015;219:576–95.
Article PubMed PubMed Central CAS Google Scholar
Lasak M, Ciepluch K. Overview of mechanism and consequences of endothelial leakiness caused by metal and polymeric nanoparticles. Beilstein J Nanotechnol. 2023;14:329–38.
Article PubMed PubMed Central CAS Google Scholar
Lenders V, Koutsoumpou X, Phan P, Soenen SJ, Allegaert K, de Vleeschouwer S, et al. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport. Chem Soc Rev. 2023;52(14):4672–724.
Article PubMed CAS Google Scholar
Hubbell JA, Chilkoti A. Chemistry nanomaterials for drug delivery. Science. 2012;337(6092):303–5.
Fatima M, Almalki WH, Khan T, Sahebkar A, Kesharwani P. Harnessing the power of stimuli-responsive nanoparticles as an effective therapeutic drug delivery system. Adv Mater. 2024;36(24): e2312939.
Immanuel J, Yun S. Vascular inflammatory diseases and endothelial phenotypes. Cells. 2023;12(12):1640.
Article PubMed PubMed Central CAS Google Scholar
Becker LM, Chen SH, Rodor J, de Rooij L, Baker AH, Carmeliet P. Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives. Cardiovasc Res. 2023;119(1):6–27.
Article PubMed CAS Google Scholar
Howard M, Zern BJ, Anselmo AC, Shuvaev VV, Mitragotri S, Muzykantov V. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano. 2014;8(5):4100–32.
Article PubMed PubMed Central CAS Google Scholar
Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater. 2023;8(4):282–300.
Article PubMed PubMed Central CAS Google Scholar
Wang L, Quine S, Frickenstein AN, Lee M, Yang W, Sheth VM, et al. Exploring and analyzing the systemic delivery barriers for nanoparticles. Adv Funct Mater. 2024;34(8):2308446.
Article PubMed CAS Google Scholar
Huang Y, Huang B, Ye D, Luo X, Xiong X, Xiong H, et al. Nano-induced endothelial leakiness-reversing nanoparticles for targeting, penetration and restoration of endothelial cell barrier. Acta Biomater. 2024;175:226–39.
Article PubMed CAS Google Scholar
Setyawati MI, Tay CY, Bay BH, Leong DT. Gold nanoparticles induced endothelial leakiness depends on particle size and endothelial cell origin. ACS Nano. 2017;11(5):5020–30.
Article PubMed CAS Google Scholar
Zhou Q, Li J, Xiang J, Shao S, Zhou Z, Tang J, et al. Transcytosis-enabled active extravasation of tumor nanomedicine. Adv Drug Deliv Rev. 2022;189:114480.
Article PubMed CAS Google Scholar
Zhou Q, Shao S, Wang J, Xu C, Xiang J, Piao Y, et al. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy. Nat Nanotechnol. 2019;14(8):799–809.
Article PubMed CAS Google Scholar
Liu GW, Guzman EB, Menon N, Langer RS. Lipid nanoparticles for nucleic acid delivery to endothelial cells. Pharm Res. 2023;40(1):3–25.
Article PubMed PubMed Central CAS Google Scholar
Liu H, Pietersz G, Peter K, Wang X. Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis. J Nanobiotechnol. 2022;20(1):75.
Choi KA, Kim JH, Ryu K, Kaushik N. Current nanomedicine for targeted vascular disease treatment: trends and perspectives. Int J Mol Sci. 2022;23(20):12397.
Article PubMed PubMed Central CAS Google Scholar
Medina-Leyte DJ, Zepeda-Garcia O, Dominguez-Perez M, Gonzalez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8):3850.
Article PubMed PubMed Central CAS Google Scholar
Xu Y, Kovacic JC. Endothelial to mesenchymal transition in health and disease. Annu Rev Physiol. 2023;85:245–67.
Article PubMed CAS Google Scholar
Kiseleva RY, Glassman PM, Greineder CF, Hood ED, Shuvaev VV, Muzykantov VR. Targeting therapeutics to endothelium: are we there yet? Drug Deliv Transl Res. 2018;8(4):883–902.
Article PubMed PubMed Central CAS Google Scholar
Nong J, Glassman PM, Muzykantov VR. Targeting vascular inflammation through emerging methods and drug carriers. Adv Drug Deliv Rev. 2022;184:114180.
Comments (0)